Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
Clinical trial NCT01786265 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01786265
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-05
- Primary completion
- 2027-02-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.